ISS is committed to the development and design of highly sensitive fluorescence instrumentation for scientific research, clinical and industrial applications. A subsidiary of ISS, ISS Medical, markets non- invasive near-infrared instrumentation for absolute measurements of oxygen and hemoglobin concentrations in tissue (brain and muscle) and functional brain imaging.
ISS has a long history of innovation beginning with time-resolved fluorometers with picosecond resolution, we manufacture fluorescence instrumentation for time-resolved (frequency-domain and time-domain) and steady-state measurements. Including, a line of modular components for fluorometers: laser diodes, LEDs, high pressure cell and fiber optic sensors amongst an extensive line of accessories.
Our microscopy line provides single molecule tracking and nanoimaging. Our Alba combines a scanning confocal lifetime imaging microscope with fluorescence correlation spectroscopy and we also provide components for microscopy: data acquisition cards for FCS and FLIM, laser launchers, galvo-scanning mirrors and detector units.
Headquartered five miles from Downtown Boston, Eureka has been around for over 100 years and we continue to drive innovation. Our goal is to regain our position as the #1 floorcare brand in the US and to expand globally. Visit www.Eureka.com to learn more and check out our new and innovative products. Midea America Corp, and Eureka Vacuums, are subsidiaries of the Global Fortune 500 company, Midea Group.
Endeavor Capital Partners is a private real estate firm actively engaged in real estate financing and investments in a diverse range of projects.
The amount of our financing and investments generally ranges from $1,000,000 - $10,000,000. The capital for Endeavor’s transactions is provided by our private fund and not arranged through intermediaries which assures our clients and partners that they will always be dealing directly with the source of the capital commitment. All of our transactions are structured from within rather than arranged through intermediaries.